A clinical trial is a research study that tests a medical treatment, drug, device, or intervention in human volunteers to determine whether it is safe and effective. These studies are the required path every new medication or therapy must travel before it can be approved for widespread use. In the United States alone, more than 400,000 studies are registered on ClinicalTrials.gov, spanning everything from cancer drugs to dietary interventions to mental health therapies.
How a Treatment Goes From Lab to People
Before any drug is tested in humans, the company or research team behind it conducts laboratory and animal studies to understand how the drug works, whether it’s likely to be safe, and whether it shows enough promise to justify human testing. Only after clearing that hurdle does it move into clinical trials, which unfold in a series of phases, each with a different goal and a larger group of participants.
Some trials also include what’s called a Phase 0 stage. This involves giving a tiny dose of a compound, less than one-hundredth of what would produce any therapeutic effect, to a small number of people. The goal isn’t to treat anything. It’s to see how the human body absorbs, distributes, and breaks down the substance. This microdosing step helps researchers weed out drug candidates that behave poorly in the human body before investing in the full safety testing of Phase I.
The Four Main Phases
Phase I enrolls a small group, typically 20 to 80 people, and focuses entirely on safety. Researchers are looking for side effects, figuring out a safe dosage range, and studying how the drug moves through the body. These participants are often healthy volunteers, not patients with the disease the drug is designed to treat.
Phase II expands to 100 to 300 people who have the condition the treatment targets. The central question shifts: does this drug actually work? Researchers also continue watching for side effects. Many promising drugs fail here. Roughly half of drugs that enter Phase II advance to the next stage.
Phase III is the large-scale confirmation step, involving 1,000 to 3,000 participants. The treatment is compared head-to-head against existing standard therapies or a placebo. This phase generates the data that regulators use to decide whether to approve the drug. It also captures rarer side effects that smaller studies might miss. About 59% of drugs that enter Phase III succeed.
Phase IV happens after a drug has already been approved and is available to the public. These studies track long-term safety in much larger and more diverse populations, looking for rare complications or new uses that weren’t apparent in earlier phases.
Overall, a drug entering Phase I has roughly a 19% chance of eventually reaching approval. The process from first-in-human testing to an approved product commonly takes a decade or more.
Interventional vs. Observational Studies
Not all clinical studies involve giving someone a treatment. In an interventional trial, researchers actively assign participants to receive a specific drug, procedure, or lifestyle change and then measure the results. In an observational study, researchers simply watch what happens naturally without intervening. They might track a large group of people over time to see how a certain exposure or behavior relates to health outcomes.
The distinction matters because interventional studies can more strongly demonstrate that a treatment caused an outcome, while observational studies can only identify associations. When you hear “clinical trial,” it almost always refers to the interventional type.
Why Trials Use Placebos and Blinding
The gold standard in clinical research is the randomized, double-blind, placebo-controlled trial. That sounds complex, but the logic is straightforward. “Randomized” means participants are assigned to the treatment or comparison group by chance, like flipping a coin. This prevents the groups from being stacked with healthier or sicker people on one side. “Double-blind” means neither the participants nor the doctors running the study know who is getting the real treatment and who is getting a placebo (an inactive substance that looks identical to the drug). This eliminates bias on both sides.
Not every trial uses this design. Some are “open label,” meaning everyone knows which treatment each participant receives. Others use an active comparator (an existing drug) instead of a placebo. The design depends on the disease being studied and what questions need answering.
Who Watches Out for Participants
Clinical trials operate under multiple layers of oversight. In the U.S., the FDA’s Center for Drug Evaluation and Research reviews the evidence at every stage. A team of physicians, statisticians, chemists, and pharmacologists evaluates whether a drug’s health benefits outweigh its known risks before granting approval.
At the local level, every trial must be reviewed and approved by an Institutional Review Board (IRB) before it can begin enrolling participants. The IRB has the authority to approve, require changes to, or reject a study. One of its most important jobs is reviewing the informed consent process.
Federal regulations require that informed consent include eight specific elements: a clear statement that the study involves research, a description of foreseeable risks, a description of potential benefits, information about alternative treatments, an explanation of how your privacy will be protected, details about compensation or medical care if you’re injured, contact information for questions, and an explicit statement that participation is voluntary. You can leave a trial at any time without penalty or losing any benefits you’re otherwise entitled to.
What It Costs to Participate
Clinical trials split costs into two categories. Research costs, like the experimental drug itself, lab tests done purely for the study, and extra imaging or doctor visits required by the trial protocol, are typically covered by the trial’s sponsor. You generally won’t pay for these.
Patient care costs are routine medical expenses you’d have whether or not you were in a trial: regular doctor visits, hospital stays, standard treatments, and tests to manage symptoms or side effects. These are usually billed to your health insurance the same way they would be otherwise.
Travel, lodging, meals, parking, and childcare can add up, especially if the trial site isn’t close to home. Some studies offer financial help for these expenses, and support organizations exist specifically to offset travel costs for trial participants. It’s worth asking the research team about available assistance before enrolling.
Diversity in Trial Enrollment
Historically, clinical trials have underrepresented women, older adults, and racial and ethnic minorities, which means approved drugs sometimes lack strong safety and effectiveness data for large segments of the population. The FDA now requires sponsors of certain clinical studies to submit diversity action plans detailing how they will improve enrollment of underrepresented groups. This mandate, established under the FDA Omnibus Reform Act, applies to specific drug and device studies and includes a formal process for the agency to review and evaluate those plans.
How to Find a Clinical Trial
ClinicalTrials.gov is the main public database for finding studies. You can search by condition or disease (such as “type 2 diabetes” or “depression”), by a specific treatment or intervention, or by location. If you’re interested in joining a study, set the Study Status filter to “Recruiting and not yet recruiting studies” to see only those actively looking for participants.
You can narrow results further using filters on the search results page: age group, study type, phase, and more. Each listing includes eligibility criteria, the study’s purpose, locations, and contact information. The number in parentheses next to each filter tells you how many registered studies match that criterion, which helps you gauge how many options exist for your situation. From there, the next step is reaching out to the research team listed on the study page to discuss whether you’re a good fit.